New and old technologies for organ replacement

Current Opinion in Organ Transplantation

Volumn 18, Issue 2, 2013, Pages 179-185

  Platt, Jeffrey L ^a   Cascalho, Marilia ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Embryonic stem cells; Organ allocation; Organogenesis; Pluripotent stem cells; Xenotransplantation

Indexed keywords

ALLOTRANSPLANTATION; CELL CLONING; CELL COUNT; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; EMBRYONIC STEM CELL; HEALTH CARE DELIVERY; HEALTH CARE NEED; HIGH RISK PATIENT; HISTOCOMPATIBILITY; HUMAN; NONHUMAN; ORGAN REPLACEMENT; ORGAN TRANSPLANTATION; ORGANOGENESIS; PLURIPOTENT STEM CELL; REVIEW; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; SURGICAL TECHNOLOGY; TISSUE REPAIR; XENOTRANSPLANTATION;

ANIMALS; EMBRYONIC STEM CELLS; HUMANS; ORGAN TRANSPLANTATION; ORGANOGENESIS; PLURIPOTENT STEM CELLS; RESOURCE ALLOCATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TISSUE ENGINEERING; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875399594     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32835f0887     Document Type: Review

References (58)

1. Cascalho M, Platt JL. Xenotransplantation and other means of organ replacement. Nat Rev Immunol 2001;1: 154-160
2. Ogle BM, Platt JL. Approaches to the replacement of the function of failing organs. Curr Opin Organ Transplant 2002;7: 28-34
3. Cascalho M, Ogle BM, Platt JL. Xenotransplantation and the future of renal replacement. J Am Soc Nephrol 2004;15: 1106-1112
4. Ogle BM, Cascalho M, Platt JL. Fusion of approaches to the treatment of organ failure. Am J Transplant 2004;4 (Suppl. 6):74-77
5. Evans RW. Coming to terms with reality: Why xenotransplantation is a necessity. In: Platt JL, editor. Xenotransplantation. Washington, D.C.: ASM Press; 2001. pp. 29-51
6. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN /SRTR 2010 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011
7. Wynn JJ, Alexander CE. Increasing organ donation and transplantation: The U.S. experience over the past decade. Transpl Int 2011;24: 324-332
8. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: A review of progress. Immunol Today 1990;11: 450-456
9. Passel JS, Cohn D. U.S. population projections: 2005-2050. Pew Research Center Social and Demographic Trends, Washington, D.C.: 2008
10. Laribi S, Aouba A, Nikolaou M, et al. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail 2012;14: 234-239
11. Starling RC. Advanced heart failure: Transplantation, LVADs, and beyond. Cleve Clin J Med 2013;80: 33-40
12. Balamurugan A, Mehta P, Bates J, Mehta JL. Change in mortality from coronary heart disease and stroke in Arkansas (1979 to 2007). Am J Cardiol 2011;107: 156-160
13. Marega A, Fregonese C, Tulissi P, et al. Preemptive liver-kidney transplantation in von Gierke disease: A case report. Transplant Proc 2011;43: 1196- 1197
14. Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 2007;4: 424-432
15. Fouzas I, Sotiropoulos GC, Molmenti EP, et al. 'Preemptive' live donor liver transplantation for fibrolamellar hepatocellular carcinoma: A case report. Transplant Proc 2008;40: 3806-3807
16. Sharma RR, London MJ, Magenta LL, et al. Preemptive surgery for premalignant foregut lesions. J Gastrointest Surg 2009;13: 1874-1887
17. Cascalho M, Platt JL. Emerging strategies in kidney transplantation: A companion to Brenner and Rector's the kidney. In: Himmelfarb J, Sayegh MH, editor. Chronic kidney disease, dialysis, and transplantation. 3rd ed. Philadelphia: Saunders; 2010. pp. 628-635
18. Cascalho M, Platt J. New technologies for organ replacement and augmentation. Mayo Clin Proc 2005;80: 370-378
19. National Research Council (U.S.). Committee on the Biological and Biomedical Applications of Stem Cell Research, Institute of Medicine (U.S.). Board on Neuroscience and Behavioral Health. Stem cells and the future of regenerative medicine. Washington, D.C.: National Academy Press; 2002
20. Anversa P, Kajstura J, Rota M, Leri A. Regenerating new heart with stem cells. J Clin Invest 2013;123: 62-70
21. National Research Council (U.S.). Committee on Guidelines for Human Embryonic Stem Cell Research, National Research Council (U.S.), Board on Health Sciences Policy, Institute of Medicine (U.S.). Guidelines for human embryonic stem cell research. Washington, D.C.: National Academies Press; 2005
22. Illmensee K, Mintz B. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci USA 1976;73: 549-553
23. Martin GR. Teratocarcinomas and mammalian embryogenesis. Science 1980;209: 768-776
24. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282: 1145-1147
25. Koch CA, Platt JL. Immunosuppression by embryonic stem cells. Stem Cells 2008;26: 89-98
26. Campbell KH, McWhir J, Ritchie WA, Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature 1996;380: 64-66
27. Cascalho M, Ogle BM, Platt JL. Organogenesis and cloning. In: Gruessner R, Benedetti E, editor. Living donor organ transplantation. New York: McGraw- Hill; 2008. pp. 769-772
28. Imberti B, Casiraghi F, Cugini D, et al. Embryonic stem cells, derived either after in vitro fertilization or nuclear transfer, prolong survival of semiallogeneic heart transplants. J Immunol 2011;186: 4164-4174
29. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126: 663-676
30. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448: 313-317
31. .Kim J, Lengner CJ, Kirak O, et al. Reprogramming of postnatal neurons into induced pluripotent stem cells by defined factors. Stem Cells 2011;29: 992- 1000
32. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature 2012;481: 295-305
33. Noggle S, Fung HL, Gore A, et al. Human oocytes reprogram somatic cells to a pluripotent state. Nature 2011;478: 70-75
34. Hansis C, Barreto G, Maltry N, Niehrs C. Nuclear reprogramming of human somatic cells by xenopus egg extract requires BRG1. Curr Biol 2004;14: 1475-1480
35. Blanpain C, Daley GQ, Hochedlinger K, et al. Stem cells assessed. Nat Rev Mol Cell Biol 2012;13: 471-476
36. Griscelli F, Feraud O, Oudrhiri N, et al. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells. Am J Pathol 2012;180: 2084-2096
37. Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011;474: 212-215
38. Barrilleaux B, Knoepfler PS. Inducing iPSCs to escape the dish. Cell Stem Cell 2011;9: 103-111
39. Carstea AC, Pirity MK, Dinnyes A. Germline competence of mouse ES and iPS cell lines: Chimera technologies and genetic background. World J Stem Cells 2009;1: 22-29
40. Lai L, Kolber-Simonds D, Park KW, et al. Production of a-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002;295: 1089-1092
41. Alipio Z, Liao W, Roemer EJ, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic betalike cells. Proc Natl Acad Sci USA 2010;107: 13426-13431
42. Jeon K, Lim H, Kim JH, et al. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Stem Cells Dev 2012;21: 2642-2655
43. Chen YF, Tseng CY, Wang HW, et al. Rapid generation of mature hepatocytelike cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology 2012;55: 1193-1203
44. Yu Y, Liu H, Ikeda Y, et al. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: Relevance to cellular therapies. Stem Cell Res 2012;9: 196-207
45. Grobstein C. Inductive epithelio-mesenchymal interaction in cultured organ rudiments of the mouse. Science 1953;118: 52-55
46. Platt JL, Brown DM, Granlund K, et al. Proteoglycan metabolism associated with mouse metanephric development: Morphologic and biochemical effects of b-D-xyloside. Dev Biol 1987;123: 293-306
47. Platt JL, Trescony P, Lindman BJ, Oegema TR. Heparin and heparan sulfate delimit nephron formation in fetal metanephric kidneys. Dev Biol 1990;139: 338-348
48. Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: Decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011;13: 27-53
49. Badylak SF, Weiss DJ, Caplan A, Macchiarini P. Engineered whole organs and complex tissues. Lancet 2012;379: 943-952
50. Sgroi A, Serre-Beinier V, Morel P, Buhler L. What clinical alternatives to whole liver transplantationöCurrent status of artificial devices and hepatocyte transplantation. Transplantation 2009;87: 457-466
51. Zhao LF, Pan XP, Li LJ. Key challenges to the development of extracorporeal bioartificial liver support systems. Hepatobiliary Pancreat Dis Int 2012;11: 243-249
52. Wertheim JA, Baptista PM, Soto-Gutierrez A. Cellular therapy and bioartificial approaches to liver replacement. Curr Opin Organ Transplant 2012;17: 235-240
53. Yu Y, Fisher JE, Lillegard JB, et al. Cell therapies for liver diseases. Liver Transpl 2012;18: 9-21
54. Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 2008;14: 213- 221
55. Hammerman MR. Transplantation of embryonic organs. Am J Transplant 2004;4 (Suppl. 6):14-24
56. Yokoo T, Fukui A, Matsumoto K, Okabe M. Stem cells and kidney organogenesis. Front Biosci 2008;13: 2814-2832
57. Ogle BM, Knudsen BE, Nishitai R, et al. Toward the development of human T cells in swine for potential use in adoptive T cell immunotherapy. Tissue Eng 2009;15: 1031-1040
58. Ogle BM, Butters KB, Plummer TB, et al. Spontaneous fusion of cells between species yields transdifferentiation and retroviral in vivo. FASEB J 2004;18: 548-550